AzTrials
AzTrials

Chronic Pelvic Pain SyndromeNCT05875545

Effects of Breathing Exercises in Women With Chronic Pelvic Pain

A study testing Breathing Exercises and Pelvic Floor Exercises in people with Chronic Pelvic Pain Syndrome and Pelvic Floor; Relaxation, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary cause of the complex interaction of chronic pelvic pain originates from the visceral organs in the pelvic cavity, and it has been observed that musculoskeletal dysfunctions (such as increased muscle activity in the pelvic floor muscles) are often accompanied by visceral painful stimuli in the pelvic region… Read more about this study

Who is it for?
Ages 18 to 45 years, women only
What is being tested?
Breathing Exercises and Pelvic Floor Exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jun 2023to 1 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Be diagnosed with chronic pelvic pain (CPA)
  • Having pelvic pain for at least 6 months
  • 18-45 years old
  • Having high resting activity of the pelvic floor (>2 microvolts based on superficial EMG (sEMG) readings)

Who cannot join

  • Having a history of pelvic cancer and/or surgery
  • Receiving radiotherapy and/or chemotherapy
  • Having a neurological and/or psychiatric pathology
  • Have a urinary tract infection
  • Menopause
  • Presence of current pregnancy status
Show all 12Show fewer
  • History of miscarriage and ectopic pregnancy
  • Presence of prolapse
  • Being >30 kg/cm2 according to body mass index (BMI)
  • Have received treatment for the pelvic area including manual therapy and electrotherapy in the last 6 months
  • Having had botulinum toxin injections in the pelvic region in the last 6 months
  • Having a communication problem

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Saglık Bilimleri University

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Clinical Effects of Breathing Exercises Combined With Pelvic Floor Exercises in Women With Chronic Pelvic Pain

The primary cause of the complex interaction of chronic pelvic pain originates from the visceral organs in the pelvic cavity, and it has been observed that musculoskeletal dysfunctions (such as increased muscle activity in the pelvic floor muscles) are often accompanied by visceral painful stimuli in the pelvic region as a result of shared innervation and visceral-somatic convergence.

This study aims to investigate the effect of breathing exercises combined with pelvic floor exercises on pain, pelvic floor muscle activity, psychological factors, and quality of life in women with chronic pelvic pain.

Being tested
Breathing Exercises, Pelvic Floor Exercises
Keywords
Women with Chronic Pelvic Pain, Breathing Exercises, Pelvic Floor Exercises

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Breathing ExercisesOther

    Diaphragmatic breathing exercises with a physiotherapist for 8 weeks, two days a week

  • Pelvic Floor ExercisesOther

    Pelvic floor exercises with a physiotherapist for 8 weeks, two days a week

Study groups in NCT05875545
Study groupRoleWhat they receive
Breathing Exercise GroupActive comparatorCombined breathing and pelvic floor exercises
Receives: Other: Breathing Exercises; Other: Pelvic Floor Exercises
Control GroupActive comparatorPelvic floor exercises
Receives: Other: Pelvic Floor Exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline Pelvic Floor Muscle Activity (PFMA) at 8 weeks

    PFMA measurement will be performed with the sEMG NeuroTrac MyoPlus Pro (Verity Medical Ltd, UK) device integrated with computer software for digital analysis and report generation.

    Measured: at the baseline and end of the 8 weeks (16 sessions)

  2. Change from Baseline Visual Analogue Scale (VAS) at 8 weeks

    Pain severity will be evaluated with the VAS.

    Measured: at the baseline and end of the 8 weeks (16 sessions)

  3. Change from Baseline McGill Pain Scale- Short Form at 8 weeks

    The scale consists of 3 parts. In the first part of the scale, a total of 3 pain scores are obtained: sensory pain score, perceptual pain score and total pain score. In the second part, there were five word groups ranging from "mild pain" to "unbearable pain" to determine the severity of the patient's pain. In the third part, the current pain intensity of the patient was evaluated using a visual comparison scale.

    Measured: at the baseline and end of the 8 weeks (16 sessions)

Secondary outcomes (5)
  1. Global Pelvic Floor Disorder Questionnaire

    Global pelvic floor disorders will be evaluated at baseline and after 8 weeks

    Measured: at the baseline and end of the 8 weeks

  2. Corbin Postural Rating Scale

    Measuring of posture changes

    Measured: at the baseline and end of the 8 weeks

  3. Pelvic Pain Impact Questionnaire

    Clinical evaluation of pelvic pain effect

    Measured: at the baseline and end of the 8 weeks

  4. Short Form-36

    Evaluation of quality of life

    Measured: at the baseline and end of the 8 weeks

  5. Depression, Anxiety and Stress Scale

    Evaluation of moods (depression, anxiety and stress)

    Measured: at the baseline and end of the 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2023
  2. Study start1 Jun 2023
  3. Primary completion1 Apr 2024
  4. Study completion1 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05875545
Sponsor's protocol ID
109 (19.10.2022)
Status last verified
Apr 2023
First submitted
2 May 2023
Last updated
20 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ, Oberpenning F, de C Williams AC; European Association of Urology. EAU guidelines on chronic pelvic pain. Eur Urol. 2010 Jan;57(1):35-48. doi: 10.1016/j.eururo.2009.08.020. Epub 2009 Aug 31.

    PubMed 19733958
  • Lamvu G, Steege JF. The anatomy and neurophysiology of pelvic pain. J Minim Invasive Gynecol. 2006 Nov-Dec;13(6):516-22. doi: 10.1016/j.jmig.2006.06.021. No abstract available.

    PubMed 17097572
  • Lamvu G, Carrillo J, Witzeman K, Alappattu M. Musculoskeletal Considerations in Female Patients with Chronic Pelvic Pain. Semin Reprod Med. 2018 Mar;36(2):107-115. doi: 10.1055/s-0038-1676085. Epub 2018 Dec 19.

    PubMed 30566976
  • Bradley MH, Rawlins A, Brinker CA. Physical Therapy Treatment of Pelvic Pain. Phys Med Rehabil Clin N Am. 2017 Aug;28(3):589-601. doi: 10.1016/j.pmr.2017.03.009. Epub 2017 May 12.

    PubMed 28676366
  • Klotz SGR MSc, PT, HS, Schon M BSc, PT, Ketels G BA, PT, HE, Lowe B MD, Brunahl CA MD. Physiotherapy management of patients with chronic pelvic pain (CPP): A systematic review. Physiother Theory Pract. 2019 Jun;35(6):516-532. doi: 10.1080/09593985.2018.1455251. Epub 2018 Mar 28.

    PubMed 29589778

Questions about this trial

What is this clinical trial studying?

A study testing Breathing Exercises and Pelvic Floor Exercises in people with Chronic Pelvic Pain Syndrome and Pelvic Floor; Relaxation, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline Pelvic Floor Muscle Activity (PFMA) at 8 weeks (time frame: at the baseline and end of the 8 weeks (16 sessions)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05875545, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2024; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in